QIAGEN (QGEN) agrees €46.50-a-share takeover framework with EQT
The proposed cash offer values the business at approximately €10.8 billion including net debt, with completion conditions still ahead.
Get analysis like this in your inbox.
Join investors and analysts following Lex Commentary.
QIAGEN announced a business-combination agreement with an EQT-controlled bidder that intends to offer €46.50 per share in cash. The company disclosed the agreement late on 21 October, following a review of strategic alternatives.
The announced enterprise value is approximately €10.8 billion, including net debt. That measure differs from the value attributable to shareholders alone, an important distinction when comparing transaction headlines.
QIAGEN's boards support the agreement. Completion will depend on conditions including a minimum tender threshold, shareholder resolutions, competition approvals and foreign-investment clearances. The transaction has therefore been agreed in framework but has not completed.
The proposed ownership group includes indirect participation by subsidiaries of the Abu Dhabi Investment Authority and CPP Investments. For shareholders, the transaction replaces a standalone growth proposition with a cash offer subject to execution risk. For the business, private ownership could change investment horizons, although the announced commitments to research, operations and employees will ultimately be tested through implementation.